Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

Shortening time to reperfusion after transfer from a primary to a comprehensive stroke center.

Sablot D, Farouil G, Laverdure A, Arquizan C, Bonafe A.

Neurol Clin Pract. 2019 Oct;9(5):417-423. doi: 10.1212/CPJ.0000000000000675.

PMID:
31750027
2.

PBI-4050 Reduces Stellate Cell Activation and Liver Fibrosis through Modulation of Intracellular ATP Levels and the Liver Kinase B1/AMP-Activated Protein Kinase/Mammalian Target of Rapamycin Pathway.

Grouix B, Sarra-Bournet F, Leduc M, Simard JC, Hince K, Geerts L, Blais A, Gervais L, Laverdure A, Felton A, Richard J, Ouboudinar J, Gagnon W, Leblond FA, Laurin P, Gagnon L.

J Pharmacol Exp Ther. 2018 Oct;367(1):71-81. doi: 10.1124/jpet.118.250068. Epub 2018 Aug 9.

PMID:
30093459
3.

Target Door-to-Needle Time for Tissue Plasminogen Activator Treatment with Magnetic Resonance Imaging Screening Can Be Reduced to 45 min.

Sablot D, Ion I, Khlifa K, Farouil G, Leibinger F, Gaillard N, Laverdure A, Bensalah ZM, Mas J, Fadat B, Smadja P, Ferraro-Allou A, Bonnec JM, Olivier N, Dutray A, Tardieu M, Dumitrana A, Guibal A, Jurici S, Bertrand JL, Allou T, Arquizan C, Bonafe A.

Cerebrovasc Dis. 2018;45(5-6):245-251. doi: 10.1159/000489568. Epub 2018 May 29.

PMID:
29843148
4.

A Newly Discovered Antifibrotic Pathway Regulated by Two Fatty Acid Receptors: GPR40 and GPR84.

Gagnon L, Leduc M, Thibodeau JF, Zhang MZ, Grouix B, Sarra-Bournet F, Gagnon W, Hince K, Tremblay M, Geerts L, Kennedy CRJ, Hébert RL, Gutsol A, Holterman CE, Kamto E, Gervais L, Ouboudinar J, Richard J, Felton A, Laverdure A, Simard JC, Létourneau S, Cloutier MP, Leblond FA, Abbott SD, Penney C, Duceppe JS, Zacharie B, Dupuis J, Calderone A, Nguyen QT, Harris RC, Laurin P.

Am J Pathol. 2018 May;188(5):1132-1148. doi: 10.1016/j.ajpath.2018.01.009. Epub 2018 Feb 16.

5.

Results of a 1-year quality-improvement process to reduce door-to-needle time in acute ischemic stroke with MRI screening.

Sablot D, Gaillard N, Colas C, Smadja P, Gely C, Dutray A, Bonnec JM, Jurici S, Farouil G, Ferraro-Allou A, Jantac M, Allou T, Pujol C, Olivier N, Laverdure A, Fadat B, Mas J, Dumitrana A, Garcia Y, Touzani H, Perucho P, Moulin T, Richard C, Heroum C, Bouly S, Sagnes-Raffy C, Heve D.

Rev Neurol (Paris). 2017 Jan - Feb;173(1-2):47-54. doi: 10.1016/j.neurol.2016.12.032. Epub 2017 Jan 26.

PMID:
28131535
6.

[Perspective of peer helpers regarding their experience animating a self-treatment program for panic disorders].

Perreault M, Bouchard S, Lapalme M, Laverdure A, Audet D, Cusson JC, Zacchia C, Milton D, Sam Tion M, Chartier-Otis M, Marchand A, Bélanger C.

Sante Ment Que. 2015 Spring;40(1):35-51. French.

PMID:
26355478
7.

Cognitive aspects of hyperactivity and overactivity in preadolescents with tourette syndrome.

Laverdure A, O'Connor K, Lavoie ME.

Psychiatry J. 2013;2013:198746. doi: 10.1155/2013/198746. Epub 2013 Mar 10.

8.

[Barriers to treatment access reported by people with anxiety disorders].

Perreault M, Lafortune D, Laverdure A, Chartier-Otis M, Bélanger C, Marchand A, Bouchard S, Milton D.

Can J Psychiatry. 2013 May;58(5):300-5. French.

PMID:
23756290
9.

Cognitive behavioral management of Tourette's syndrome and chronic tic disorder in medicated and unmedicated samples.

O'Connor KP, Laverdure A, Taillon A, Stip E, Borgeat F, Lavoie M.

Behav Res Ther. 2009 Dec;47(12):1090-5. doi: 10.1016/j.brat.2009.07.021. Epub 2009 Aug 5.

10.

Cognitive-behaviour therapy and skilled motor performance in adults with chronic tic disorder.

O'Connor KP, Lavoie ME, Stip E, Borgeat F, Laverdure A.

Neuropsychol Rehabil. 2008 Jan;18(1):45-64.

11.

Demonstration of a cell-specific isomerization of invertebrate neuropeptides.

Soyez D, Laverdure AM, Kallen J, Van Herp F.

Neuroscience. 1998 Feb;82(3):935-42.

PMID:
9483547
12.
13.

Neuropeptides and related nucleic acid sequences detected in peneid shrimps by immunohistochemistry and molecular hybridizations.

Laverdure AM, Carette-Desmoucelles C, Breuzet M, Descamps M.

Neuroscience. 1994 May;60(2):569-79.

PMID:
8072696
14.
15.
16.

[Quantitation of nuclear RNA synthesis in the ovary of adult Tenebrio molitor].

Chaminade MM, Laverdure AM, Wolff E.

C R Acad Hebd Seances Acad Sci D. 1976 Mar 29;282(13):1297-300. French.

PMID:
819171
17.

[In vitro culture of the ovaries of Tenebrio molitor. Juvenile hormone, vitellogenesis, and survival of young oöcytes].

Laverdure AM.

J Insect Physiol. 1975 Jan;21(1):33-8. French. No abstract available.

PMID:
1120912
18.

[Hormonal conditions necessary for evolution of the ovary in the pupa of Tenebrio molitor (Coleoptera)].

Laverdure AM.

Gen Comp Endocrinol. 1971 Dec;17(3):467-78. No abstract available.

PMID:
5166855
19.

[Action of ecdysone on the nymphal ovary of Tenebrio molitor (coleopter) cultivated in vitro].

Laverdure AM.

Annee Biol. 1970 Jul-Oct;9(7):455-63. French. No abstract available.

PMID:
5489261
20.

[Effect of ecdysone and methyl ester of farnesol on the nymphal ovary of Tenebrio molitor (Coleoptera) cultivated in vitro].

Laverdure AM.

Ann Endocrinol (Paris). 1970 May-Jun;31(3):516-24. French. No abstract available.

PMID:
5455244
22.

[Culture in vitro of the ovaries of Tenebrio molitor (Coleoptera). Importance of the composition of the medium on survival, growth and vitellogenesis].

Laverdure AM.

C R Acad Hebd Seances Acad Sci D. 1967 Aug 7;265(6):505-7. French. No abstract available.

PMID:
4963556
23.

[Culture in vitro of the ovaries of Tenebrio molitor (Coleoptera). Growth and vitellogenesis].

Lender T, Laverdure AM.

C R Acad Hebd Seances Acad Sci D. 1967 Jul 31;265(5):451-4. French. No abstract available.

PMID:
4963548
24.

[Mechanism of action of the corpora allata during vitellogenesis in Tenebrio molitor (Coleoptera)].

Laverdure AM.

C R Acad Hebd Seances Acad Sci D. 1967 Jul 10;265(2):145-6. French. No abstract available.

PMID:
4963650
25.

[Role of the cephalic complex during the vitellogenesis of Tenebrio molitor (Coleoptera)].

Lender T, Laverdure AM.

C R Acad Hebd Seances Acad Sci D. 1965 Jul 12;261(2):557-9. French. No abstract available.

PMID:
4954645

Supplemental Content

Loading ...
Support Center